Le cluster Irina Isakova-Sivak - Larisa Rudenko
000048 (2019) | Irina Isakova-Sivak [Russie] ; Victoria Matyushenko [Russie] ; Tatiana Kotomina [Russie] ; Irina Kiseleva [Russie] ; Elena Krutikova [Russie] ; Svetlana Donina [Russie] ; Andrey Rekstin [Russie] ; Natalia Larionova [Russie] ; Daria Mezhenskaya [Russie] ; Konstantin Sivak [Russie] ; Arman Muzhikyan [Russie] ; Anastasia Katelnikova [Russie] ; Larisa Rudenko [Russie] | Sequential Immunization with Universal Live Attenuated Influenza Vaccine Candidates Protects Ferrets against a High-Dose Heterologous Virus Challenge |
000142 (2018) | Larisa Rudenko ; Irina Kiseleva ; Elena Krutikova ; Ekaterina Stepanova ; Irina Isakova-Sivak ; Svetlana Donina ; Andrey Rekstin ; Maria Pisareva ; Ekaterina Bazhenova ; Tatiana Kotomina ; Anastasia Katelnikova ; Arman Muzhikyan ; Valery Makarov ; Erin Grace Sparrow ; Guido Torelli | Two Live Attenuated Vaccines against Recent Low–and Highly Pathogenic H7N9 Influenza Viruses Are Safe and Immunogenic in Ferrets |
000297 (2017) | Andrey Rekstin [Russie] ; Irina Isakova-Sivak [Russie] ; Galina Petukhova [Russie] ; Daniil Korenkov [Russie] ; Igor Losev [Russie] ; Tatiana Smolonogina [Russie] ; Tatiana Tretiak [Russie] ; Svetlana Donina [Russie] ; Svetlana Shcherbik [États-Unis] ; Tatiana Bousse [États-Unis] ; Larisa Rudenko [Russie] | Immunogenicity and Cross Protection in Mice Afforded by Pandemic H1N1 Live Attenuated Influenza Vaccine Containing Wild-Type Nucleoprotein |
000458 (2016) | Irina Isakova-Sivak [Russie] ; Daniil Korenkov [Russie] ; Tatiana Smolonogina [Russie] ; Tatiana Tretiak [Russie] ; Svetlana Donina [Russie] ; Andrey Rekstin [Russie] ; Anatoly Naykhin [Russie] ; Svetlana Shcherbik [États-Unis] ; Nicholas Pearce [États-Unis] ; Li-Mei Chen [États-Unis] ; Tatiana Bousse [États-Unis] ; Larisa Rudenko [Russie] | Comparative studies of infectivity, immunogenicity and cross-protective efficacy of live attenuated influenza vaccines containing nucleoprotein from cold-adapted or wild-type influenza virus in a mouse model |
000561 (2015) | Irina Isakova-Sivak [Russie] ; Marina Stukova [Russie] ; Mariana Erofeeva [Russie] ; Anatoly Naykhin [Russie] ; Svetlana Donina [Russie] ; Galina Petukhova [Russie] ; Victoria Kuznetsova [Russie] ; Irina Kiseleva [Russie] ; Tatiana Smolonogina [Russie] ; Irina Dubrovina [Russie] ; Maria Pisareva [Russie] ; Alexandra Nikiforova [Russie] ; Maureen Power [États-Unis] ; Jorge Flores [États-Unis] ; Larisa Rudenko [Russie] | H2N2 live attenuated influenza vaccine is safe and immunogenic for healthy adult volunteers |
000563 (2015) | Irina Kiseleva [Russie] ; Irina Dubrovina [Russie] ; Ekaterina Fedorova [Russie] ; Natalie Larionova [Russie] ; Irina Isakova-Sivak [Russie] ; Ekaterina Bazhenova [Russie] ; Maria Pisareva [Russie] ; Victoria Kuznetsova [Russie] ; Jorge Flores [États-Unis] ; Larisa Rudenko [Russie] | Genetic stability of live attenuated vaccines against potentially pandemic influenza viruses. |
000730 (2014) | Irina Isakova-Sivak [Russie] ; J Rgen De Jonge [Pays-Bas] ; Tatiana Smolonogina [Russie] ; Andrey Rekstin [Russie] ; Geert Van Amerongen [Pays-Bas] ; Harry Van Dijken [Pays-Bas] ; Justin Mouthaan [Pays-Bas] ; Paul Roholl [Pays-Bas] ; Victoria Kuznetsova [Russie] ; Elena Doroshenko [Russie] ; Vadim Tsvetnitsky [États-Unis] ; Larisa Rudenko [Russie] | Development and Pre-Clinical Evaluation of Two LAIV Strains against Potentially Pandemic H2N2 Influenza Virus |
000C38 (2011) | Larisa Rudenko [Russie] ; Han Van Den Bosch ; Irina Kiseleva ; Alexander Mironov ; Anatoly Naikhin ; Natalie Larionova ; Dimitry Bushmenkov | Live attenuated pandemic influenza vaccine: clinical studies on A/17/California/2009/38 (H1N1) and licensing of the Russian-developed technology to WHO for pandemic influenza preparedness in developing countries. |
000C60 (2011) | Irina Isakova-Sivak [États-Unis] ; Li-Mei Chen ; Yumiko Matsuoka ; J Theo M. Voeten ; Irina Kiseleva ; Jacco G M. Heldens ; Han Van Den Bosch ; Alexander Klimov ; Larisa Rudenko ; Nancy J. Cox ; Ruben O. Donis | Genetic bases of the temperature-sensitive phenotype of a master donor virus used in live attenuated influenza vaccines: A/Leningrad/134/17/57 (H2N2). |
000D62 (2011) | Larisa Rudenko [Russie, Australie] ; Han Van Den Bosch [Pays-Bas] ; Irina Kiseleva [Russie, Australie] ; Alexander Mironov [Russie] ; Anatoly Naikhin [Russie] ; Natalie Larionova [Russie] ; Dimitry Bushmenkov [Russie] | Live attenuated pandemic influenza vaccine: Clinical studies on A/17/California/2009/38 (H1N1) and licensing of the Russian-developed technology to WHO for pandemic influenza preparedness in developing countries |
000090 (2019) | Svetlana Shcherbik [États-Unis] ; Nicholas Pearce [États-Unis] ; Paul Carney [États-Unis] ; Ekaterina Bazhenova [Russie] ; Natalie Larionova [Russie] ; Irina Kiseleva [Russie] ; Larisa Rudenko [Russie] ; Amrita Kumar [États-Unis] ; Cynthia S. Goldsmith [États-Unis] ; Vivien Dugan [États-Unis] ; James Stevens [États-Unis] ; David E. Wentworth [États-Unis] ; Tatiana Bousse [États-Unis] | Evaluation of A(H1N1)pdm09 LAIV vaccine candidates stability and replication efficiency in primary human nasal epithelial cells |
000294 (2017) | Irina Kiseleva [Russie] ; Natalie Larionova [Russie] ; Larisa Rudenko [Russie] | Live Attenuated Reassortant Vaccines Based on A/Leningrad/134/17/57 Master Donor Virus Against H5 Avian Influenza. |
000439 (2016) | Svetlana Shcherbik [États-Unis] ; Nicholas Pearce [États-Unis] ; Irina Kiseleva [Russie] ; Natalie Larionova [Russie] ; Larisa Rudenko [Russie] ; Xiyan Xu [États-Unis] ; David E. Wentworth [États-Unis] ; Tatiana Bousse [États-Unis] | Implementation of new approaches for generating conventional reassortants for live attenuated influenza vaccine based on Russian master donor viruses. |
000449 (2016) | J Rgen De Jonge [Pays-Bas] ; Irina Isakova-Sivak [Russie] ; Harry Van Dijken [Pays-Bas] ; Sanne Spijkers [Pays-Bas] ; Justin Mouthaan [Pays-Bas] ; Rineke De Jong [Pays-Bas] ; Tatiana Smolonogina [Russie] ; Paul Roholl [Pays-Bas] ; Larisa Rudenko [Russie] | H7N9 Live Attenuated Influenza Vaccine Is Highly Immunogenic, Prevents Virus Replication, and Protects Against Severe Bronchopneumonia in Ferrets. |
000699 (2014) | Andrey Rekstin [Russie] ; Yulia Desheva [Russie] ; Irina Kiseleva [Russie] ; Ted Ross [États-Unis] ; David Swayne [États-Unis] ; Larisa Rudenko [Russie] | Live Attenuated Influenza H7N3 Vaccine is Safe, Immunogenic and Confers Protection in Animal Models. |
000741 (2014) | Irina Isakova-Sivak [États-Unis, Russie] ; Li-Mei Chen [États-Unis] ; Melissa Bourgeois [États-Unis] ; Yumiko Matsuoka [États-Unis] ; J. Theo M. Voeten [Pays-Bas] ; Jacco G. M. Heldens [Pays-Bas] ; Han Van Den Bosch [Pays-Bas] ; Alexander Klimov [États-Unis] ; Larisa Rudenko [Russie] ; Nancy J. Cox [États-Unis] ; Ruben O. Donis [États-Unis] | Characterization of Reverse Genetics-Derived Cold-Adapted Master Donor Virus A/Leningrad/134/17/57 (H2N2) and Reassortants with H5N1 Surface Genes in a Mouse Model |
000C81 (2011) | Kortney M. Gustin [États-Unis] ; Taronna R. Maines ; Jessica A. Belser ; Neal Van Hoeven ; Xuihua Lu ; Libo Dong ; Irina Isakova-Sivak ; Li-Mei Chen ; J Theo M. Voeten ; Jacco G M. Heldens ; Han Van Den Bosch ; Nancy J. Cox ; Terrence M. Tumpey ; Alexander I. Klimov ; Larisa Rudenko ; Ruben O. Donis ; Jacqueline M. Katz | Comparative immunogenicity and cross-clade protective efficacy of mammalian cell-grown inactivated and live attenuated H5N1 reassortant vaccines in ferrets. |
000D64 (2011) | Kortney M. Gustin [Géorgie] ; Taronna R. Maines [Géorgie] ; Jessica A. Belser [Géorgie] ; Neal Van Hoeven [Géorgie] ; XUIHUA LU [Géorgie] ; LIBO DONG [Géorgie] ; Irina Isakova-Sivak [Géorgie, Russie] ; Li-Mei Chen [Géorgie] ; J. Theo M. Voeten [Pays-Bas] ; Jacco G. M. Heldens [Pays-Bas] ; Han Van Den Bosch [Pays-Bas] ; Nancy J. Cox [Géorgie] ; Terrence M. Tumpey [Géorgie] ; Alexander I. Klimov [Géorgie] ; Larisa Rudenko [Russie] ; Ruben O. Donis [Géorgie] ; Jacqueline M. Katz [Géorgie] | Comparative Immunogenicity and Cross-Clade Protective Efficacy of Mammalian Cell-Grown Inactivated and Live Attenuated H5N1 Reassortant Vaccines in Ferrets |
001225 (2008) | Larisa Rudenko [Russie] ; Julia Desheva ; Sergey Korovkin ; Alexander Mironov ; Andrey Rekstin ; Elena Grigorieva ; Svetlana Donina ; Alexandra Gambaryan ; Anton Katlinsky | Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I-II clinical trials). |
000223 (2018) | Yulia Desheva [Russie] ; Ivan Sychev [Russie] ; Tatiana Smolonogina [Russie] ; Andrey Rekstin [Russie] ; Natalia Ilyushina [États-Unis] ; Vladimir Lugovtsev [États-Unis] ; Anastasia Samsonova [États-Unis] ; Aleksey Go [Russie] ; Anna Lerner [Russie] | Anti-neuraminidase antibodies against pandemic A/H1N1 influenza viruses in healthy and influenza-infected individuals |
000533 (2015) | Larisa Rudenko [Russie] ; Irina Isakova-Sivak | Pandemic preparedness with live attenuated influenza vaccines based on A/Leningrad/134/17/57 master donor virus. |
000747 (2014) | Svetlana Shcherbik [États-Unis] ; Sheila B. Sergent ; William G. Davis ; Bo Shu ; John Barnes ; Irina Kiseleva ; Natalie Larionova ; Alexander Klimov ; Tatiana Bousse | Application of real time RT-PCR for the genetic homogeneity and stability tests of the seed candidates for live attenuated influenza vaccine production. |
001653 (2004) | Thomas Palker [États-Unis] ; Irina Kiseleva ; Kimberly Johnston ; Qin Su ; Timothy Toner ; Christopher Szymkowiak ; Wan-Sang Kwan ; Boris Rubin ; Luba Petrukhin ; Joan Wlochowski ; Juanita Monteiro ; Nikolai Kraiouchkine ; Daniel Distefano ; Larisa Rudenko ; Alan Shaw ; Rima Youil | Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants. |
000F44 (2010) | J. Theo M. Voeten [Pays-Bas] ; Irina V. Kiseleva [Pays-Bas, Russie] ; Harrie L. Glansbeek [Pays-Bas] ; Stephanie M. C. Basten [Pays-Bas] ; Sandra K. M. Drieszen-Van Der Cruijsen [Pays-Bas] ; Larisa G. Rudenko [Russie] ; Han Van Den Bosch [Pays-Bas] ; Jacco G. M. Heldens [Pays-Bas] | Master donor viruses A/Leningrad/134/17/57 (H2N2) and B/USSR/60/69 and derived reassortants used in live attenuated influenza vaccine (LAIV) do not display neurovirulent properties in a mouse model |
000F88 (2010) | J. Theo [Pays-Bas] ; M. Voeten [Pays-Bas] ; Irina V. Kiseleva [Russie] ; Harrie L. Glansbeek [Pays-Bas] ; Stephanie M. C. Basten [Pays-Bas] ; Sandra K. M. Drieszen-Van Der Cruijsen [Pays-Bas] ; Larisa G. Rudenko [Russie] ; Han Van Den Bosch [Pays-Bas] ; Jacco G. M. Heldens [Pays-Bas] | Master donor viruses A/Leningrad/134/17/57 (H2N2) and B/USSR/60/69 and derived reassortants used in live attenuated influenza vaccine (LAIV) do not display neurovirulent properties in a mouse model |
001914 (2000) | Larisa G. Rudenko [Russie] ; Nancy H. Arden [États-Unis] ; Elena Grigorieva [Russie] ; Anatoli Naychin [Russie] ; Andrei Rekstin [Russie] ; Alexander I. Klimov [États-Unis] ; Svetlana Donina [Russie] ; Julia Desheva [Russie] ; Robert C. Holman [États-Unis] ; Angel Deguzman [Russie] ; Nancy J. Cox [États-Unis] ; Jacqueline M. Katz [États-Unis] | Immunogenicity and efficacy of Russian live attenuated and US inactivated influenza vaccines used alone and in combination in nursing home residents |
This area was generated with Dilib version V0.6.33. |